Multiple congenital hemangioma in the scrotal area: case report
DOI:
https://doi.org/10.56294/saludcyt2022173Keywords:
Multiple Congenital Hemangioma, Newborn, Vascular NeoplasmAbstract
Congenital hemangiomas are vascular tumors, which are classified as rapidly involuted and non-involuted. They mainly affect the Caucasian population, the distribution by sex is not significant. In most cases no treatment is required due to involution, however, when this is not the case the clinical picture of a hemangioma may be associated with complications such as: ulcers, soft tissue destruction, neoformations even with infection of the injured tissue. The present case report presents a 7-month-old patient with multiple congenital hemangiomas of non-involutive type that led to a process of ulceration with subsequent superinfection in the scrotal area involving soft tissue. The treatment was clinical and surgical, a selective beta-blocker was used, with a favorable prognosis of the patient
References
1. Boull C, Maguiness SM. Congenital hemangiomas. Seminars in Cutaneous Medicine and Surgery. 2016; 35(3):124-7. https://doi.org/10.12788/j.sder.2016.045
2. Amouri M, Mesrati H, Chaaben H, Masmoudi A, Mseddi M, Turk, H. Congenital hemangioma. Cutis. 2017; 99(1), E31-E33.
3. Kilcline C, Frieden IJ. Infantile Hemangiomas: How Common Are They? A Systematic Review of the Medical Literature. Pediatric Dermatology. 2008, 25(2), 168–173. https://doi.org/10.1111/j.1525-1470.2008.00626.x
4. Mulliken JB, Enjolras O. Congenital hemangiomas and infantile hemangioma: missing links. Journal of the American Academy of Dermatology. 2004; 50(6), 875–882. https://doi.org/10.1016/j.jaad.2003.10.670
5. Moran-Villaseñor E, Campos-Cabrera BL, García-Romero MT, Duran-McKinster C. Anomalías vasculares más frecuentes en pacientes pediátricos. Parte 1: Tumores vasculares. Acta Pediatr Mex. 2020; 41(1):26-39. http://dx.doi.org/10.18233/APM41No1pp26-391973
6. Liang MG, Frieden IJ. Infantile and congenital hemangiomas. Seminars in Pediatric Surgery. 2014; 23(4), 162–167. http://doi.org/10.1053/j.sempedsurg.2014.06.017
7. Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma. The Lancet. 2017; 390(10089), 85–94. https://doi.org/10.1016/S0140-6736(16)00645-0
8. Baselga Torres E, Bernabéu Wittel J, van Esso Arbolave DL, Febrer Bosch MI, Carrasco Sanz Á, de Lucas Laguna R, et al. Consenso español sobre el hemangioma infantil. Anales de Pediatría. 2016; 85(5):256–65. Available: http://doi.org/10.1016/j.anpedi.2015.10.004
9. Stuepp R, Scotti F, Melo G, Andrade Munhoz E, Modolo F. Effects of sclerosing agents on head and neck hemangiomas: A systematic review. Journal section: Oral Medicine and Pathology. 2019; 11(11):e1033-44. https://doi.org/10.4317/jced.56143
10. Léaute-Labrèze C., Boccara O., Degrugillier-Chopinet C., Mazereeuw-Hautier J., Prey S., Lebbé G., Gautier S., Ortis V., Lafon M., Montagne A., Delarue A., Voisard J. Safety of Oral Propranolol for the Treatment of Infantile Hemangioma: A Systematic Review. Pediatrics. 2016; 138 (4). https://doi.org/10.1542/peds.2016-0353
11. Calderón-Castrat X, Velásquez F, Castro R, Ballona R. Atenolol oral en el manejo del hemangioma infantil: serie de casos de 46 pacientes. Actas Dermo-Sifiliográficas. 2020 ;111(1):59–62. https://doi.org/10.1016/j.ad.2019.03.015
Published
Issue
Section
License
Copyright (c) 2022 Tita Fernández de Jiménez, Roberto Carlos Jiménez Fernández, Jhossmar Cristians Auza-Santiváñez (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
